Tome Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Employees
  • 130

Employees

  • Latest Deal Type
  • Out of Business

Tome Biosciences General Information

Description

Operator of a biotechnology company intended to offer programmable gene insertion technology. The company helps to insert any genetic sequence of any size at any location in any genome to detect and destroy deoxyribonucleic acid from similar bacteriophages during subsequent infections, enabling patients to be cured through cell and genome engineering.

Contact Information

Website
www.tome.bio
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Talcott Avenue
  • Watertown, MA 02472
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 100 Talcott Avenue
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tome Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 03-Nov-2025 Completed Out of Business
2. Early Stage VC (Series B) 12-Dec-2023 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2022 $95.5M $95.5M Completed Generating Revenue
To view Tome Biosciences’s complete valuation and funding history, request access »

Tome Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-2
Series A 24,306,564 $0.000100 6% $1.22 $1.22 1x $1.22 17.63%
To view Tome Biosciences’s complete cap table history, request access »

Tome Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to offer programmable gene insertion technology. The company helps to inser
Biotechnology
Watertown, MA
130 As of 2024

Dublin, Ireland
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tome Biosciences Competitors (45)

One of Tome Biosciences’s 45 competitors is ERS Genomics, a Corporate Backed or Acquired company based in Dublin, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ERS Genomics Corporate Backed or Acquired Dublin, Ireland
Regenxbio Formerly VC-backed Rockville, MD
Selecta Biosciences Formerly VC-backed Watertown, MA
Precision BioSciences Formerly VC-backed Durham, NC
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 5 of 45 competitors. Get the full list »

Tome Biosciences Patents

Tome Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025050069-A1 Programmable gene insertion using engineered integration enzymes Inactive 01-Sep-2023
WO-2024234006-A1 Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs) Inactive 11-May-2023
WO-2024138194-A1 Platforms, compositions, and methods for in vivo programmable gene insertion Inactive 22-Dec-2022
WO-2024020587-A2 Pleiopluripotent stem cell programmable gene insertion Inactive 22-Jul-2022
WO-2024020587-A3 Pleiopluripotent stem cell programmable gene insertion Inactive 22-Jul-2022 C12N15/1138
To view Tome Biosciences’s complete patent history, request access »

Tome Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tome Biosciences Acquisitions (1)

Tome Biosciences’s most recent deal was a Merger/Acquisition with Replace Therapeutics for . The deal was made on 02-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Replace Therapeutics 02-Jan-2024 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Tome Biosciences’s complete acquisitions history, request access »

Tome Biosciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Replace Therapeutics Emeryville, CA 2022

Tome Biosciences FAQs

  • When was Tome Biosciences founded?

    Tome Biosciences was founded in 2021.

  • Where is Tome Biosciences headquartered?

    Tome Biosciences is headquartered in Watertown, MA.

  • What is the size of Tome Biosciences?

    Tome Biosciences has 130 total employees.

  • What industry is Tome Biosciences in?

    Tome Biosciences’s primary industry is Biotechnology.

  • Is Tome Biosciences a private or public company?

    Tome Biosciences is a Private company.

  • What is Tome Biosciences’s current revenue?

    The current revenue for Tome Biosciences is .

  • How much funding has Tome Biosciences raised over time?

    Tome Biosciences has raised $213M.

  • Who are Tome Biosciences’s competitors?

    ERS Genomics, Regenxbio, Selecta Biosciences, Precision BioSciences, and Genetix Biotherapeutics are some of the 45 competitors of Tome Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process